Quarterly report [Sections 13 or 15(d)]

Accounts Payable and Related Party (Tables)

Accounts Payable and Related Party (Tables)

6 Months Ended

Jun. 30, 2025

Payables and Accruals [Abstract]

Schedule of Accounts Payable

Accounts payable consist of the following:

Schedule of Accounts Payable

		As of								As of
		June 30, 2025				%				December 31, 2024				%
Accounts payable to Cytovance, a related party ¹		$	598,000				44	%		$	1,183,000				31	%
Accounts payable to University of Minnesota			432,000				31	%			712,000				18	%
Legal services firm			—				—	%			1,505,000				39	%
Accounts payable			—				—	%			1,505,000				39	%
Other accounts payable			344,000				25	%			453,000				12	%
Total accounts payable		$	1,374,000				100	%		$	3,853,000				100	%

¹	Accounts Payable to Cytovance, a related party, since Cytovance owns greater than 5% of the Company’s issued and outstanding common stock. See Note 7 – Commitments and Contingencies, Significant Agreements.

Schedule of Accounts Payable to Related Party

The details of the Company’s accounts payable to Cytovance were as follows:

		June 30, 2025				June 30, 2024
		Six Months Ending
		June 30, 2025				June 30, 2024
		(Unaudited)				(Unaudited)
Beginning balance		$	1,183,000			$	3,515,000
Invoices, net			626,000				778,000
Payments in cash			(364,000	)			(2,641,000	)
Payments in common stock, at fair value			—				(810,000	)
Payments in pre-funded warrants, at fair value			(847,000	)			—
Ending balance		$	598,000			$	842,000